Lumen Meds review

Take a quarter dose here and you pay what a full dose costs — Lumen says "Same price, every dose" and then prints the whole milligram ladder beside the single figure, which is exactly how that claim should be made. Most providers assert it and publish nothing you could check it against. Lumen publishes both halves in the same card, and publishes a LegitScript identifier rather than an unlinked badge image. The problem is which figure you meet first. The price on the homepage is the twelve-month total divided by twelve, labeled only "/Month". The real month-to-month rate is more than twice that on semaglutide and nearly twice on tirzepatide, and it does not appear on the marketing pages at all. There is also a pricing tier inside its own checkout cheaper than anything advertised, and nothing on the site explains what it is or who gets it.

Vs median

$74/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate

Market

$59–$1,300/mo is the full published spread on this site

Structure

Same price at every dose

Consult

Included in the price

Dietitian

Not confirmed

Labs

Not required

Pricing

Flat at every dose

Lumen Meds does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.

Lumen Meds sells compounded semaglutide (with B12) and compounded tirzepatide (with B6) as once-weekly self-injections on a flat monthly plan, offered month to month or on three-, six- and twelve-month terms. Its plan card states the pricing basis and then evidences it, printing the full milligram range each flat price covers directly beside the figure — the promise and the thing that makes it checkable in the same place. It publishes a LegitScript seal identifier. Its marketing headline is not its month-to-month rate: the figure on the homepage is the twelve-month total divided by twelve. No compounding pharmacy is named beyond "Partnered with U.S. 503A pharmacies", and no state list is published.

ONE PRICE AT EVERY DOSE, stated outright. A patient holding at 0.25 mg/week pays the same as one at 2.5 mg, and Lumen prints both ends of that range next to the single figure

• THE HOMEPAGE FIGURE IS NOT A MONTHLY RATE. The $114.99 semaglutide and $191.99 tirzepatide headlines are the twelve-month totals divided by twelve. The month-to-month rates are $249.99 and $349.99 — 2.2× and 1.8× higher — and appear nowhere on the marketing pages
• A pricing tier named "PRICE_V2" sits in the checkout at $129.99 semaglutide and $179.99 tirzepatide, below every advertised figure, and nothing on the site says what it is or who qualifies for it
• With scripts blocked the headline price renders as "$0 00 Month" — the figure is counted up in the browser rather than served with the page
• "Premium GLP-1 Treatments — Delivered to Your Door at the Lowest Price in the Industry" is an unqualified superlative sitting above a figure that is an annual rate
• No compounding pharmacy is named beyond "U.S. 503A pharmacies", and no state list is published
• Compounded GLP-1s are not FDA-approved, and intentional microdosing is off-label and unproven

Lumen Meds is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.

Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.

• What the evidence actually shows
• What microdosing GLP-1 costs
• Low dose vs full dose
• What a flat price costs at a low dose
• The true annual cost of a plan